Prognostic value of homocysteinemia in patients with congestive heart failure

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 7, 2006, Pages 813-816

  Gibelin, Pierre ^a   Serre, Stephanie ^a   Candito, Mirande ^b   Houcher, Bakhouche ^c   Berthier, Frederic ^d   Baudouy, Marcel ^a  

^a PASTEUR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c Setif 1 University   (Algeria)

^d University of Côte d'Azur   (France)

Author keywords

Ejection fraction; Heart failure; Homocysteinemia; NYHA classification; Prognosis

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; VITAMIN DEFICIENCY;

EID: 33745224744     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.138     Document Type: Article

References (19)

1. Kannel W. Incidence and epidemiology of heart failure. Heart Fail Rev 2000;5:167-73.
2. Roger V, Weston S, Redfield M, Hellermann-Homan J, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. J Am Med Assoc 2004;292:344-50.
3. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset S. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
4. Alfthan G, Aro A, Gey KF. Plasma homocysteine and cardiovascular disease mortality. Lancet 1997;349:397.
5. Wald N, Watt H, Law M, Weir D, McPartlin J, Scott J. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 1998;158:862-7.
6. Wald D, Law M, Morris J. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 2002;325:1202-13.
7. Blann AD. Endothelial cell damage and homocysteine. Atherosclerosis 1992;94:89-91.
8. Al-Shaer M, Raghuveer G, Browning R, Sinkey C, Chenard C, Stumbo P, et al. Effect of hyperhomocysteinemia induced by methionine administration on flow-mediated dilatation of the brachial artery in healthy subjects. Am J Cardiol 2005;95:428-30.
9. Kennedy R, Owings R, Shekhawat N, Joseph J. Acute negative inotropic effects of homocysteine are mediated via the endothelium. Am J Physiol Heart Circ Physiol 2004;287:H812-7.
10. Ventura P, Panini R, Verlato C, Scarpetta G, Salvioli G. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Metabolism 2001;50:1466-71.
11. Vasan R, Beiser A, D'Agostino R, Levy D, Selhub J, Jacques P, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. J Am Med Assoc 2003;289:1251-7.
12. Sundstrom J, Vasan R. Homocysteine and heart failure: a review of investigations from the Framingham Heart Study. Clin Chem Lab Med 2005;43:987-92.
13. Sundstrom J, Sullivan L, Selhub J, Benjamin E, D'Agostino R, Jacques P, et al. Relations of plasma homocysteine to left ventricular structure function: Framingham Heart Study. Eur Heart J 2004;25:523-30.
14. Herrmann M, Kindermann I, Müller S, Georg T, Kindermann M, Böhm M, et al. Relationship of plasma homocysteine with the severity of chronic heart failure. Clin Chem 2005;10:1512-5.
15. Joseph J, Joseph L, Shekhawat N, Devi S, Wang J, Melchert R, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003;285:H679-86.
16. Joseph J, Kennedy R, Devi S, Wang J, Joseph L, Hauer-Jensen M. Protective role of mast cells in homocysteine-induced cardiac remodeling. Am J Physiol Heart Circ Physiol 2005;288:H2541-5.
17. Norlund L, Grubb A, Fex G, Leskell H, Nilsson JE, Schenck H, et al. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998;36:175-8.
18. Henning BF, Riezler R, Tepel M, Langer K, Raidt H, Graefe U, et al. Evidence of altered homocysteine metabolism in chronic renal failure. Nephron 1999;83:314-22.
19. Andersson S, Edvinsson M, Edvinsson L. Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity. Basic Clin Pharmacol Toxicol 2005;97:306-10.